April 26, 2020 / 1:09 AM / a month ago

BRIEF-Diasorin Obtains FDA Emergency Use Authorization And Barda Funding For Sars-Cov-2 Igg Serology Kit For Covid-19 Testing In The U.S.

April 25 (Reuters) - DiaSorin SpA:

* DIASORIN OBTAINS FDA EMERGENCY USE AUTHORIZATION AND BARDA FUNDING FOR SARS-COV-2 IGG SEROLOGY KIT FOR COVID-19 TESTING IN THE U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below